DK239388D0 - Fremgangsmaade til behandling af ikke-specifik inflammation - Google Patents
Fremgangsmaade til behandling af ikke-specifik inflammationInfo
- Publication number
- DK239388D0 DK239388D0 DK239388A DK239388A DK239388D0 DK 239388 D0 DK239388 D0 DK 239388D0 DK 239388 A DK239388 A DK 239388A DK 239388 A DK239388 A DK 239388A DK 239388 D0 DK239388 D0 DK 239388D0
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- treating non
- specific inflammation
- inflammation
- subject
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11579787A | 1987-11-02 | 1987-11-02 | |
US11579787 | 1987-11-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK239388D0 true DK239388D0 (da) | 1988-05-03 |
DK239388A DK239388A (da) | 1989-05-03 |
DK175491B1 DK175491B1 (da) | 2004-11-08 |
Family
ID=22363440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198802393A DK175491B1 (da) | 1987-11-02 | 1988-05-03 | Anvendelse af ICAM-1 og dets funktionelle derivater til behandling af ikke-specifik inflammation |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0314863B1 (da) |
JP (1) | JP2710627B2 (da) |
AT (1) | ATE114972T1 (da) |
AU (2) | AU1550988A (da) |
CA (1) | CA1331132C (da) |
DE (1) | DE3852374T2 (da) |
DK (1) | DK175491B1 (da) |
ES (1) | ES2064327T3 (da) |
GR (1) | GR3015298T3 (da) |
ZA (1) | ZA883160B (da) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68929096T2 (de) | 1988-09-01 | 2000-05-11 | Bayer Corp., Pittsburgh | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
AU4412889A (en) * | 1988-09-28 | 1990-04-18 | Dana-Farber Cancer Institute | Intercellular adhesion molecules, and their binding ligands |
CA2008368C (en) * | 1989-01-24 | 2003-04-08 | Jeffrey Greve | Soluble molecule related to but distinct from icam-1 |
US5235049A (en) * | 1989-01-24 | 1993-08-10 | Molecular Therapeutics, Inc. | Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 |
NO900155L (no) * | 1989-01-24 | 1990-07-25 | Molecular Therapeutics Inc | Et opploeselig molekyl som er relatert til, men forskjellig fra icam-1. |
US5776775A (en) * | 1989-02-21 | 1998-07-07 | Dana-Farber Cancer Institute | Anti-LAM 1-3 antibody and hybridoma |
DK0387701T3 (da) * | 1989-03-09 | 1992-12-07 | Boehringer Ingelheim Pharma | Anvendelse af intercellulære adhæsionsmolekyler samt deres bindende ligander ved behandling af astma |
WO1990015076A2 (en) * | 1989-06-02 | 1990-12-13 | The Johns Hopkins University School Of Medicine | MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
EP0438312A3 (en) * | 1990-01-19 | 1992-07-01 | Merck & Co. Inc. | Recombinant human anti-cd18 antibodies |
NZ236792A (en) * | 1990-01-19 | 1993-05-26 | Merck & Co Inc | Recombinant human anti-cd18 antibody, murine 1b4 heavy or light chain variable region, dna, vectors, mammalian host and pharmaceutical compositions |
GB9009549D0 (en) * | 1990-04-27 | 1990-06-20 | Celltech Ltd | Recombinant antibody and method |
WO1991018011A1 (en) * | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
WO1991018010A1 (en) * | 1990-05-15 | 1991-11-28 | Swinburne Limited | Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof |
DE4019024A1 (de) * | 1990-06-14 | 1991-12-19 | Bayer Ag | Verwendung der efomycine a, e und g als entzuendungshemmende mittel |
DK162890D0 (da) * | 1990-07-06 | 1990-07-06 | Novo Nordisk As | Polypeptid |
US5871733A (en) * | 1990-07-20 | 1999-02-16 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
DE69131564T2 (de) * | 1990-07-20 | 2000-01-13 | Bayer Corp., Pittsburgh | Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins |
US5686581A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
US5283058A (en) * | 1990-08-30 | 1994-02-01 | The General Hospital Corporation | Methods for inhibiting rejection of transplanted tissue |
DE69129460T2 (de) * | 1990-08-31 | 1998-10-15 | Boehringer Ingelheim Pharma | Verwendung von Anti-ICAM Antikörpern zur Herstellung eines Präparats für die BEHANDLUNG VON ENDOTOXINSCHOCK |
WO1992008489A1 (en) * | 1990-11-08 | 1992-05-29 | Biogen, Inc. | Treatment for inflammatory bowel disease |
CZ96893A3 (en) * | 1990-11-23 | 1993-12-15 | Gen Hospital Corp | Inhibition of adhesive protein cells and their carbohydrates interaction |
US5288854A (en) * | 1990-11-28 | 1994-02-22 | Center For Blood Research, Inc. | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
US5223396A (en) * | 1991-05-03 | 1993-06-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for detecting organ transplant rejection |
US5629162A (en) * | 1991-06-11 | 1997-05-13 | The Center For Blood Research | Method of identifying agents which modulate ICAM-3 binding to LFA-1 |
JPH07502727A (ja) * | 1991-10-01 | 1995-03-23 | ザ・ジエネラル・ホスピタル・コーポレーシヨン | 接着分子に対する抗体を用いた同種移植片拒絶の防止 |
JP3679112B2 (ja) * | 1991-10-04 | 2005-08-03 | アメリカ合衆国 | 細胞接着分子の遮断による眼の炎症の治療 |
GB9126918D0 (en) * | 1991-12-19 | 1992-02-19 | Univ London | Members of specific binding pairs;methods of their making and using |
US5525487A (en) * | 1992-01-27 | 1996-06-11 | Icos Corporation | DNA encoding I-CAM related protein |
US5869262A (en) * | 1992-01-27 | 1999-02-09 | Icos Corporation | Method for monitoring an inflammatory disease state by detecting circulating ICAM-R |
US6100383A (en) * | 1992-01-27 | 2000-08-08 | Icos Corporation | Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions |
US5532127A (en) * | 1992-01-27 | 1996-07-02 | Icos Corporation | Assay for 1-CAM related protein expression |
US6818743B1 (en) | 1992-01-27 | 2004-11-16 | Icos Corporation | I-CAM related protein |
US5837822A (en) * | 1992-01-27 | 1998-11-17 | Icos Corporation | Humanized antibodies specific for ICAM related protein |
US6153395A (en) * | 1992-01-27 | 2000-11-28 | Icos Corporation | ICAM-related protein |
JP3616090B2 (ja) * | 1992-01-27 | 2005-02-02 | イコス コーポレイション | 細胞間接着分子関連タンパク質 |
US5989843A (en) * | 1992-01-27 | 1999-11-23 | Icos Corporation | Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein |
US5932214A (en) * | 1994-08-11 | 1999-08-03 | Biogen, Inc. | Treatment for inflammatory bowel disease with VLA-4 blockers |
JPH07506566A (ja) * | 1992-02-12 | 1995-07-20 | バイオゲン インコーポレイテッド | 炎症性胃腸病の処置 |
DE69326829D1 (de) | 1992-02-28 | 1999-11-25 | Univ Texas | Verwendung einer therapeutischen ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON VERBRENNUNGEN |
ES2112431T3 (es) * | 1992-08-21 | 1998-04-01 | Genentech Inc | Procedimiento para el tratamiento de un trastorno mediado por lfa-1. |
DE4335273A1 (de) * | 1993-10-15 | 1995-04-20 | Univ Ludwigs Albert | Peptide zur Tumortherapie |
US5679340A (en) * | 1994-03-31 | 1997-10-21 | Diacrin, Inc. | Cells with multiple altered epitopes on a surface antigen for use in transplantation |
WO1995027736A1 (en) * | 1994-04-12 | 1995-10-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection |
GB9414966D0 (en) * | 1994-07-26 | 1994-09-14 | Danbiosyst Uk | Pharmaceutical compositions for the nasal administration of antiviral agents |
US5879712A (en) * | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
US6391452B1 (en) | 1997-07-18 | 2002-05-21 | Bayer Corporation | Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations |
US6670321B1 (en) | 1998-12-30 | 2003-12-30 | The Children's Medical Center Corporation | Prevention and treatment for retinal ischemia and edema |
CA2544678C (en) | 2003-11-05 | 2013-12-31 | Sunesis Pharmaceuticals, Inc. | Modulators of cellular adhesion |
PL2444079T3 (pl) | 2005-05-17 | 2017-07-31 | Sarcode Bioscience Inc. | Kompozycje i sposoby leczenia chorób oczu |
GB0525214D0 (en) | 2005-12-12 | 2006-01-18 | Bioinvent Int Ab | Biological materials and uses thereof |
CA2702984C (en) | 2007-10-19 | 2017-04-11 | Sarcode Corporation | Compositions and methods for treatment of diabetic retinopathy |
US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
WO2011050175A1 (en) | 2009-10-21 | 2011-04-28 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
JP6607780B2 (ja) | 2012-07-25 | 2019-11-20 | サルコード・バイオサイエンス・インコーポレイテッド | Lfa−1阻害剤およびその多形 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE128727T1 (de) * | 1987-05-04 | 1995-10-15 | Dana Farber Cancer Inst Inc | Interzellulare adhäsions-moleküle und deren bindungsliganden. |
-
1988
- 1988-04-29 AT AT88106902T patent/ATE114972T1/de not_active IP Right Cessation
- 1988-04-29 ES ES88106902T patent/ES2064327T3/es not_active Expired - Lifetime
- 1988-04-29 DE DE3852374T patent/DE3852374T2/de not_active Expired - Lifetime
- 1988-04-29 EP EP88106902A patent/EP0314863B1/en not_active Expired - Lifetime
- 1988-05-02 CA CA000565640A patent/CA1331132C/en not_active Expired - Lifetime
- 1988-05-02 JP JP63109819A patent/JP2710627B2/ja not_active Expired - Lifetime
- 1988-05-03 DK DK198802393A patent/DK175491B1/da not_active IP Right Cessation
- 1988-05-03 AU AU15509/88A patent/AU1550988A/en not_active Withdrawn
- 1988-05-04 ZA ZA883160A patent/ZA883160B/xx unknown
- 1988-11-29 AU AU26333/88A patent/AU622120B2/en not_active Expired
-
1995
- 1995-03-03 GR GR950400476T patent/GR3015298T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA1331132C (en) | 1994-08-02 |
AU1550988A (en) | 1989-07-27 |
AU622120B2 (en) | 1992-04-02 |
ES2064327T3 (es) | 1995-02-01 |
GR3015298T3 (en) | 1995-06-30 |
EP0314863B1 (en) | 1994-12-07 |
ATE114972T1 (de) | 1994-12-15 |
AU2633388A (en) | 1989-07-27 |
EP0314863A2 (en) | 1989-05-10 |
DE3852374T2 (de) | 1995-05-04 |
DE3852374D1 (de) | 1995-01-19 |
JPH01135724A (ja) | 1989-05-29 |
DK175491B1 (da) | 2004-11-08 |
EP0314863A3 (en) | 1990-04-04 |
JP2710627B2 (ja) | 1998-02-10 |
DK239388A (da) | 1989-05-03 |
ZA883160B (en) | 1990-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK239388D0 (da) | Fremgangsmaade til behandling af ikke-specifik inflammation | |
DK592286D0 (da) | Fremgangsmaade til dannelse af silicium-diffusionsbelaegninger paa metalartikler | |
DK607689A (da) | Fremgangsmaade til behandling af laeder | |
ES499887A0 (es) | Procedimiento e instalacion para el tratamiento de residuos agricolas liquidos | |
DK442783D0 (da) | Fremgangsmade til fremstilling af et immobiliseret enzympraeparat | |
DK151636C (da) | Fremgangsmaade til immobilisering af en enzymproducerende mikroorganisme eller det af denne producerede enzym | |
DK188481A (da) | Fremgangsmaade til fremstilling af et organisk platinkompleks | |
NO885029L (no) | Fremgangsmaate og anordning for presisjons-anbringelse av gjenstander paa faste konstruksjoner paa dypt vann. | |
DK52278A (da) | Fremgangsmaade til behandling af spildevand samt apparat til udoevelse af fremgangsmaaden | |
DK322583D0 (da) | Middel til behandling af sar | |
IT7847961A0 (it) | Procedimento per il trattamento di fanghiglie di scarico | |
ES521476A0 (es) | Metodo perfeccionado para el tratamiento de lodos de aguas residuales. | |
DK597886A (da) | Fremgangsmaade til paafoering af tryk paa laedersubstrater | |
DK543286A (da) | Fremgangsmaade til inhibering af hydrogeninduceret korrosion af metalliske materialer | |
DK54781A (da) | Fremgangsmaade og anlaeg til automatisk regulering af taendingen af en motor med styret taending | |
DK4786A (da) | Fremgangsmaade til behandling af biomasse | |
ES501527A0 (es) | Procedimiento para el endurecimiento de resinas insaturadas | |
DK130786A (da) | Fremgangsmaade til acceleration af fikseringen af chromatholdige traebeskyttelsessalte | |
MX159993A (es) | Metodo para controlar el grueso de un revestimiento electrodepositado | |
DK36984D0 (da) | Apparat til behandling af ar | |
AR230845A1 (es) | Procedimiento para el tratamiento de sustratos de acero o de acero galvanizado | |
DK225282A (da) | Fremgangsmaade til isomerisering af et o,o-dialkylphosphoramidothiat | |
DK135785D0 (da) | Fremgangsmaade til fremstilling af et antibiotisk stof | |
ATA311386A (de) | Einrichtung zur kompensation der hochschlagund rueckstossenergie von faustfeuerwaffen | |
DK441482A (da) | Fremgangsmaade til anaerob fermentering af spildevand |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |